Advertisement
Screener

Histogen Inc. Deferred Tax Assets, Valuation Allowance

Histogen Inc. Deferred Tax Assets, Valuation Allowance

Histogen Inc. had Deferred Tax Assets, Valuation Allowance of $24.69 million as of 2022-12-31, per its 10-K filed 2023-03-09.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-03-09

  • 2022-12-31: Deferred Tax Assets, Valuation Allowance $24.69M.
  • 2021-12-31: Deferred Tax Assets, Valuation Allowance $22.86M.
  • 2020-12-31: Deferred Tax Assets, Valuation Allowance $17.54M.
  • 2019-12-31: Deferred Tax Assets, Valuation Allowance $13.30M; Deferred Tax Assets, Valuation Allowance as first filed $44.87M.
Period endDeferred Tax Assets, Valuation AllowanceDeferred Tax Assets, Valuation Allowance as first filed
2022-12-31$24.69M
10-K · filed 2023-03-09
2021-12-31$22.86M
10-K · filed 2023-03-09
2020-12-31$17.54M
10-K · filed 2022-03-10
2019-12-31$13.30M
10-K · filed 2021-03-11
$44.87M
10-K · filed 2020-03-11
2018-12-31$45.57M
10-K · filed 2020-03-11
2017-12-31$41.12M
10-K · filed 2019-03-08
2016-12-31$50.08M
10-K · filed 2018-03-08
2015-12-31$39.89M
10-K · filed 2017-03-16
2014-12-31$29.63M
10-K · filed 2016-03-11
2013-12-31$20.74M
10-K · filed 2015-03-13
2012-12-31$24.13M
10-K · filed 2014-03-28